Company to submit Investigational Device Exemption (IDE) to FDA for novel CBGM technology in Spring 2026 Expanded clinical advisory team with appointment…
Company to submit Investigational Device Exemption (IDE) to FDA for novel CBGM technology in Spring 2026
Expanded clinical advisory team with appointment of pain management and medical technology expert, Usman Latif, MD, MBA
Strengthened balance shee… [14037 chars]
Source: GlobeNewswire | Published: 2025-11-13T00:00:00Z
Credit: GlobeNewswire
